The objective of the Recruitment and Retention Shared Facility (RRSF) is to provide an infrastructure to recruit subjects to cancer control and therapeutic trials with expertise and emphasis on targeting minorities, women, and older individuals. To achieve this goal, the facility: 1) provides diverse recruitment services (developing recruitment strategies and materials;recruiting and scheduling subjects, etc.);2) provides the necessary linkage between CCC researchers and the surrounding communities;3) and maintains information systems with Recruitment Data Bases (RDB), Recruitment Tracking System (RTS), and Health Profile System (HPS) to identify subjects with health profiles of interest to investigators. Since its inception, the RRSF demonstrated success in recruiting participants primarily for large population-based clinical trials. More than 70,000 persons were recruited and screened for research studies; 23,103 participants were enrolled in 19 cancer studies;30% of these participants were African-American (a population of specific interest in our growing number of NIH-funded projects). More recent efforts focused on developing new strategies to recruit participants specifically for therapeutic clinical trials. An NCI-funded model program was implemented entitled """"""""Increasing Minority Participation in Clinical Trials"""""""" (IMPaCT) through Patient Navigation. IMPaCT aims to provide equal access to clinical trials for low-resource and minority patients by helping them overcome barriers to participation and move through the healthcare system. UAB is now the lead institution to provide training to implement the IMPaCT Patient Navigation program in five additional Cancer Centers with an emphasis on minority populations: the University of Minnesota, the University of Texas-MD Anderson, Johns Hopkins, and University of California-Davis. In addition, an IMPaCT Administrative Supplement was funded to extend the project to Cooper Green Mercy Hospital (CGMH), a county hospital that serves indigent patients in Birmingham. This project offers the opportunity to participate in clinical trials to CGMH patients who previously had no access to clinical trials, and the project forges new collaborations between CCC investigators and CGMH physicians. In addition, our experience with the IMPaCT Patient Navigation also resulted in a National Center on Minority Health and Health Disparities grant to create a national consortium to implement and evaluate new strategies to reduce health disparities by enhancing enrollment of minorities in cancer clinical trials. This national-level work rests upon the RRSF's continued success in providing excellent recruiting support for the UAB-CCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-42
Application #
8738175
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
42
Fiscal Year
2014
Total Cost
$137,057
Indirect Cost
$63,251
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Subramaniam, Akila; Blanchard, Christina T; Erickson, Britt K et al. (2018) Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol 132:20-27
Kasten, Benjamin B; Oliver, Patsy G; Kim, Harrison et al. (2018) 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models. Int J Mol Sci 19:
Stoll, Matthew L; Weiss, Pamela F; Weiss, Jennifer E et al. (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:14
Garner, Evan F; Williams, Adele P; Stafman, Laura L et al. (2018) FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts. Sci Rep 8:6913
Locke, Landon W; Kothandaraman, Shankaran; Tweedle, Michael et al. (2018) Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. Tuberculosis (Edinb) 108:201-210
Fancy, Romone M; Kim, Harrison; Napier, Tiara et al. (2018) Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells. J Cell Biochem 119:6216-6230
Barrington, David A; Champion, Macie L; Boitano, Teresa K L et al. (2018) Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic. Gynecol Oncol 149:337-340
Banerjee, N Sanjib; Wang, Hsu-Kun; Beadle, James R et al. (2018) Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures. Antiviral Res 150:164-173
Keene, Kimberly S; King, Tari; Hwang, E Shelley et al. (2018) Molecular determinants of post-mastectomy breast cancer recurrence. NPJ Breast Cancer 4:34
Kleinpeter, Alex B; Jureka, Alexander S; Falahat, Sally M et al. (2018) Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds. J Biol Chem 293:14659-14668

Showing the most recent 10 out of 747 publications